Swapnroop Drugs & Pharmaceuticals is a Regdanvimab API manufacturer, supplier, and exporter in India, offering Regdanvimab biologic active pharmaceutical ingredient sourcing and supply support for biopharmaceutical research, formulation development, analytical requirements, and international pharmaceutical projects.
Regdanvimab is a recombinant human monoclonal antibody targeting the receptor-binding domain of the SARS-CoV-2 spike protein. It is associated with neutralizing antibody and antiviral biopharmaceutical applications.
We focus on consistent product quality, controlled sourcing, batch-to-batch reliability, appropriate biologic handling, and comprehensive technical documentation. Regdanvimab API requirements can be supported according to customer-specific quality parameters and applicable biopharmaceutical specifications.
We support Regdanvimab API and biologic active substance requirements for biopharmaceutical companies, biotechnology organizations, contract research organizations, research institutions, pharmaceutical distributors, and authorized international buyers.
Our Regdanvimab API supply services support:
Regdanvimab API is evaluated according to applicable biologic quality parameters, analytical methods, product specifications, and customer requirements.
Typical Quality Parameters Include:
Appearance: Clear to slightly opalescent solution or as per specification
Identification: Complies with specification
Protein Concentration: As per approved specification
Purity: As per specification
Purity by SEC-HPLC: As per approved specification
Charge Variants: Within specified limits
High Molecular Weight Species: Within specified limits
Low Molecular Weight Species: Within specified limits
Binding Activity: As per validated biological assay
Biological Activity / Potency: As per approved specification
SARS-CoV-2 Spike Protein Binding Activity: As per specification
Neutralizing Activity: As per validated biological assay
pH: As per approved specification
Endotoxin: Within specified limits
Bioburden: As applicable
Sterility: As applicable
Host Cell Protein: Within specified limits
Residual Host Cell DNA: Within specified limits
Residual Protein A: Within specified limits, as applicable
Particulate Matter: As per applicable requirements
Actual specifications may vary depending on manufacturing process, expression system, purification process, formulation, analytical methods, intended use, development stage, regulatory requirements, and customer-approved specifications.
Regdanvimab API is associated with the biopharmaceutical industry as a recombinant monoclonal antibody active substance targeting the SARS-CoV-2 spike protein.
Regdanvimab is a neutralizing monoclonal antibody associated with antiviral biopharmaceutical research and therapeutic applications involving SARS-CoV-2 infection.
Its biological activity is associated with binding to the receptor-binding domain of the SARS-CoV-2 spike protein and interfering with interaction between the viral spike protein and the human ACE2 receptor. This mechanism supports inhibition of viral entry into susceptible human cells.
Regdanvimab API is primarily intended for use by licensed biopharmaceutical manufacturers, biotechnology organizations, formulation development companies, research institutions, contract research organizations, and authorized pharmaceutical organizations.
Swapnroop Drugs & Pharmaceuticals offers reliable Regdanvimab API sourcing and supply support for domestic and international biopharmaceutical requirements.
Our Key Advantages:
We support the export and international supply coordination of Regdanvimab API and biologic pharmaceutical materials from India to pharmaceutical companies, biotechnology organizations, research institutions, distributors, and authorized buyers across international markets.
Export documentation and product information can be provided based on destination-country requirements, customer specifications, intended use, cold-chain requirements, and applicable regulatory procedures.
We serve pharmaceutical and biopharmaceutical buyers across Asia, Africa, the Middle East, Latin America, and other international pharmaceutical markets.
Looking for a reliable Regdanvimab API manufacturer in India, Regdanvimab API supplier in India, or Regdanvimab API exporter from India?
Contact Swapnroop Drugs & Pharmaceuticals for Regdanvimab API requirements, technical documentation, COA, SDS, pricing, packaging details, biologic handling information, and export inquiries.
Company: Swapnroop Drugs & Pharmaceuticals
Product: Regdanvimab API
CAS Number: 2444308-95-4
Supply Type: Biologic API / Monoclonal Antibody Active Substance
Country of Origin: India
Email: enquiry@sdp.org.in